Cipher Pharmaceuticals (TSE:CPH) Shares Pass Above 50 Day Moving Average - Time to Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR's share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$12.48 and traded as high as C$12.89. Cipher Pharmaceuticals shares last traded at C$12.49, with a volume of 43,554 shares.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$12.50 target price on shares of Cipher Pharmaceuticals and gave the stock a "hold" rating in a report on Monday, April 7th.

Cipher Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00. The company has a market capitalization of C$222.62 million, a PE ratio of 13.69 and a beta of 1.20. The stock's fifty day simple moving average is C$12.49 and its 200-day simple moving average is C$13.36.

Insider Buying and Selling at Cipher Pharmaceuticals

In other Cipher Pharmaceuticals news, Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total transaction of C$47,215.00. 42.00% of the stock is currently owned by corporate insiders.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.